DLD and metabolic disease: By coupling a rapid chiral LC–MS/MS readout with metagenomic d-ldh profiling and a stable-isotope tracer, it will be possible to construct a “D-lactate burden score” that can be tested in cohorts with inflammatory or metabolic diseases.